The prospect of cancer recovery in Germany

Medical care in Germany is one of the best in the world. German medicine presents prominent results in the field of oncology. The studies have shown that survival rates for almost all types of cancer in Germany are higher than in other European countries.

About the EuroCare-5 study

The aim of the EuroCare-5 study was to evaluate the significant progress in the diagnosis, treatment and rehabilitation in oncological diseases. Researchers analyzed the data from 107 cancer registries in 1999-2007, with more than 10 million patients with cancer diagnosis. The focus of the study was the relative 5-year survival rate of the patients. The EUROCARE project provides the most extensive data sets for comparison of standardized survival rates in oncological diseases in Europe.

 

The relative 5-year survival rate (data in percent)

  • Stomach cancer

  • Colon cancer

  • Rectal cancer

  • Lung cancer

  • Skin cancer

  • Breast cancer

  • Ovarian cancer

  • Prostate cancer

  • Kidney cancer

  • Non-Hodgkin’s lymphoma

    • Germany31,3%

    • Europe25,1%

    • Southern Europe29,6%

    • Eastern Europe18,8%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany62,6%

    • Europe57,0%

    • Southern Europe58,5%

    • Eastern Europe49,4%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany60,2%

    • Europe55,8%

    • Southern Europe55,4%

    • Eastern Europe49,4%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany15,6%

    • Europe13,0%

    • Southern Europe13,2%

    • Eastern Europe10,6%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany89,4%

    • Europe83,2%

    • Southern Europe82,6%

    • Eastern Europe74,3%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany83,6%

    • Europe81,8%

    • Southern Europe83,6%

    • Eastern Europe73,7%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany40,3%

    • Europe37,6%

    • Southern Europe38,0%

    • Eastern Europe34,4%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany89,4%

    • Europe83,4%

    • Southern Europe86,3%

    • Eastern Europe72,0%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany70,2%

    • Europe60,6%

    • Southern Europe64,4%

    • Eastern Europe57,5%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010

    • Germany63,5%

    • Europe59,4%

    • Southern Europe58,7%

    • Eastern Europe49,7%

    Source: The Lancet , Volume 385 , Issue 9972 , 977 – 1010